Table 2.
Compound | C0 (mg/mL) | C1 (mg/mL) | LE (%), n = 3 |
---|---|---|---|
CS–INH | 5 | 0.282 | 94.36 ± 0.7 |
CS–INH-a | 5 | 0.52 | 89.60 ± 0.9 |
CS–INH-b | 5 | 0.39 | 92.17 ± 0.8 |
CS–INH-c | 5 | 0.45 | 90.89 ± 0.7 |
Compound | C0 (mg/mL) | C1 (mg/mL) | LE (%), n = 3 |
---|---|---|---|
CS–INH | 5 | 0.282 | 94.36 ± 0.7 |
CS–INH-a | 5 | 0.52 | 89.60 ± 0.9 |
CS–INH-b | 5 | 0.39 | 92.17 ± 0.8 |
CS–INH-c | 5 | 0.45 | 90.89 ± 0.7 |